PLATINUM2024

Jacinto Convit World Organization, Inc.

Our mission is to give access to better healthcare solutions to those who need it the most, while training the new generations

aka JCWO   |   POMPANO BEACH, FL   |  https://www.jacintoconvit.org/

Mission

The Jacinto Convit World Organization contributes primarily to important areas of public health, such as cancer and endemic infectious diseases in developing countries with poor health conditions, preserving the legacy of Dr. Jacinto Convit, a renowned physician, scientist and humanist. Inspired in the vision of creating social impact through science, the Jacinto Convit World Organization has a multidisciplinary team of professionals that work with commitment, communication and diversity of capabilities to help those that need it the most and make a positive impact in our society.

Ruling year info

2015

President

Ana Federica Convit

Main address

508 MISTY OAKS DR

POMPANO BEACH, FL 33069 USA

Show more contact info

EIN

46-4905774

NTEE code info

Science, General (includes Interdisciplinary Scientific Activities) (U20)

IRS filing requirement

This organization is required to file an IRS Form 990-N.

Sign in or create an account to view Form(s) 990 for 2022, 2021 and 2020.
Register now

Communication

Programs and results

What we aim to solve

SOURCE: Self-reported by organization

For many people around the world, having access to molecular techniques used in diagnosis or control of diseases is as simple as any other basic blood test. However, this is not the case for most developing countries. Therefore we support the expansion of the Molecular Diagnostic Unit run by partner organizations in South America, within our Molecular Diagnostics program. In low-income countries, many patients do not have access to new innovative therapies and in some cases, to standard of care treatments. To bring to them effective and accessible immunotherapies will make an impact in these patients life and improve the local health care system.

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Molecular Diagnostics

Considering the improved survival rates for childhood cancer when an early and precise diagnose is performed, JCWO builds international support for the Molecular Diagnostic Unit; a pioneer program that consists of a personalized, precise, and free of cost diagnostic service for pediatric cancers and endemic infectious diseases for underprivileged children that are treated in public hospitals in South America.

Population(s) Served
Children and youth
Adults

This program seeks to make Dr. Convit’s breast cancer immunotherapy a standard low cost treatment option for patients. Through partnerships with research and health centers, JCWO works to advance its clinical trials in the US, South America and Europe using the ConvitVax. Additionally, this program looks to further enhance the anti-tumor effect of the ConvitVax by testing it in combination with other breast cancer therapies, as well as evaluate it as a treatment for other types of malignant solid tumors. With this program we direct our efforts to develop accessible immunotherapy protocols that can be affordable for underprivileged patients who lack the possibility of entering new innovative treatments.

Population(s) Served
People with diseases and illnesses
Economically disadvantaged people

Where we work

Our results

SOURCE: Self-reported by organization

How does this organization measure their results? It's a hard question but an important one.

Number of overall donors

This metric is no longer tracked.
Totals By Year
Type of Metric

Other - describing something else

Direction of Success

Increasing

Number of attorney volunteers

This metric is no longer tracked.
Totals By Year
Type of Metric

Input - describing resources we use

Direction of Success

Holding steady

Context Notes

Since our inception, we receive the support of two important law firms.

Number of research studies conducted

This metric is no longer tracked.
Totals By Year
Related Program

Cancer Immunotherapy

Type of Metric

Output - describing our activities and reach

Direction of Success

Holding steady

Number of adults satisfied with the health care system in the community

This metric is no longer tracked.
Totals By Year
Population(s) Served

Adults, Children and youth

Related Program

Molecular Diagnostics

Type of Metric

Output - describing our activities and reach

Direction of Success

Increasing

Context Notes

To date, 7,230 diagnoses have been made, benefiting 1,446 patients and 5,784 relatives and patient representatives.

Number of children who have access to healthcare

This metric is no longer tracked.
Totals By Year
Population(s) Served

Children and youth

Related Program

Molecular Diagnostics

Type of Metric

Output - describing our activities and reach

Direction of Success

Increasing

Number of new organizations signing on as collaborators

This metric is no longer tracked.
Totals By Year
Type of Metric

Other - describing something else

Direction of Success

Increasing

Context Notes

Organizations or individual persons as collaborators

Number of Facebook followers

This metric is no longer tracked.
Totals By Year
Type of Metric

Other - describing something else

Direction of Success

Increasing

Context Notes

Additionally, there are 560 followers on Linkedin, 305 on Twitter and 458 on Instagram.

Our Sustainable Development Goals

SOURCE: Self-reported by organization

Learn more about Sustainable Development Goals.

Goals & Strategy

SOURCE: Self-reported by organization

Learn about the organization's key goals, strategies, capabilities, and progress.

Charting impact

Four powerful questions that require reflection about what really matters - results.

Our current efforts are centered on two main programs, Molecular Diagnostics and Cancer Immunotherapy.
The Molecular Diagnostics program is based on supporting the expansion of the Molecular Diagnostic Unit in South America. It consists on a personalized, precise, and free of cost diagnostic service for cancers and endemic infectious diseases for underprivileged patients (mainly children) that are treated in public hospitals of the region.
The Cancer Immunotherapy program seeks to make Dr. Convit’s cancer immunotherapy a standard low cost treatment option for cancer patients. Through partnerships with research and health centers, JCWO works to advance in the execution of clinical trials in South America, the U.S. and Europe, using the ConvitVax as a treatment for breast cancer and other solid tumors. This immunotherapy is specially targeted to poor countries where there is very little or no access to new cancer treatments and in some cases to standard of care treatments.
Our goals and activities for this year are:
Project development
Alliances
Fundraising
Dissemination
Human Resources

We want to development theses sttategies:
Establish with AJVaccine the necessary documentation for the shipment of BCG and PPD.
Finalize the clinical protocol with the specialists.
Adjust the format and send clinical protocol to FDA.
Establish allies in the USA and Spain for the execution of the clinical trial.
Support the development of the new combination pre-clinical protocol.
Support in data processing and writing of the manuscript.
Organize and write the Leishmaniasis project
Review of WHO requirements and application for approval.
Find interested institutions in the leishmaniasis vaccine and sign an agreement or submit application
Create a database of countries and centers for the diagnosis of solid tumors.
Prepare the solid tumors project for the diagnostic service.
Send the project to interested centers in tumor solid diagnostics and sign an agreement.
Find new cooperative institutions with whom JCWO can partner to performing a clinical trial inside and outside the US.
Hold meetings where JCWO can present the clinical trial and establish alliances for its different projects
Arrange the material and send partnership requests to the institutions listed in the data base, and keep contact with those that agree to participate in the clinical trial.
Sign collaboration agreements with hospitals for clinical trial execution.
Find organizations that want to collaborate in the scientific and educational programs of JCWO.
Send letters and set up meetings with the necessary requests for the programs.
Follow up and establish agreements with the organizations contacted that can support JCWO
Arrange agreements with institutions or universities that can support the JCWO programs.
Continue to expand the database of organizations and institutions for the application of financing.
Submit grant applications for the scientific programs in which JCWO can qualify.
Create new strategies for the search and raising of funds (campaigns, meetings, among others)
Generate a database of companies with social corporate responsibility to request funds.
Contact through calls and letters for the presentation of programs and request for financing to individuals and companies
Establish strategies with different tools, such as Google Ads and other digital fundraising platforms, to promote donations for the organization.
Keep the website updated and generate new content monthly

We have an excellent multidisciplinary team that is totally capable and willing to engage in the tasks that are necessary to achieve our goals. We are a young organization that is quickly growing, and as we believe in teamwork we attempt to increase our alliances worldwide. No big goal can be achieved by only one organization, and this is why our networking efforts are part of our daily work. In this sense, we now have the important support of a few companies and individuals that help us succeed in our work. Today we have 4 signed agreement of collaborators for the area of clinical trials and technology. In addition, since the inception 23 interns have been trained in different areas of the organization such as: communications, design, language and healthcare.

Achievements
Cancer Immunotherapy
ConvitVax in clinical trials
As part of JCWO’s objectives, an important effort was made with the support of the ad-honorem specialist team to significantly improve the clinical protocol to the highest standards in accordance to the standards of the National Cancer Institute. The first trial is expected to begin in Venezuela, as soon as their top regulatory authority, Instituto Nacional de Higiene Rafael Rangel, gives their final approval. The first review has already been carried out and the corrections were delivered to the regulatory authority.

ConvitVax in pre-clinical studies
To continue the pre-clinical studies of the vaccine, a new study was designed in which ConvitVax is combined with CTLA-4. This design was reviewed and corrected by the team of researchers and Scientific Advisor. The experiment is expected to begin this year at FJC’s facilities with the support of JCWO.

Agreements
The Danish BCG vaccine producer of strain 1331, AJ Vaccines A/S, reviewed and approved JCWO’s clinical protocol -already authorized by the FDA- to conduct a phase I trial in 40 metastatic breast cancer patients, using ConvitVax with their BCG vaccine, for which they will guarantee the product supply. Additionally, AJ Vaccine A / S will supply the PPD test for monitoring the immune response of patients as established in the clinical protocol. JCWO has already signed an agreement in which it undertakes to notify any side effects generated by the PPD and currently the agreement between the two organizations is under review by the company's legal department.
Publications
In September 2020, after several years of recovering and compiling information on the life and work of Doctor Jacinto Convit, we were pleased and proud to publish in a peer-reviewed journal the biography titled " Biografía Doctor Jacinto Convit: Médico, científico, docente y humanista" in Gaceta Medica de Caracas (Huerta, et al. 2020). This publication represents the first and most complete official biography of Dr. Jacinto Convit.

The vaccine toxicity work entitled "Toxicity Evaluation of the ConvitVax - an autologous breast cancer vaccine - in a murine model" was submitted for review by the indexed journal Scientific Report. Currently, the organization is correcting the observations made by the reviewers and the inclusion of pathological data from the main organs evaluated.

Funding for JCWO’s programs
This year the fundraising area was strongly boosted. During 2020 we sent aproximately 394 letters to request funds (companies, institutions, banks), and 118 grant applications. Until now, we have received rejections from 69 applications; however, others 49 are pending for resolution. Additionally, due to the pandemic, resources and donations have been directed mainly to face this problem. Next year's intensive search for funding and new strategies will continue in order to find the necessary resources for our programs and to cover operational costs.

Financials

Jacinto Convit World Organization, Inc.
lock

Unlock financial insights by subscribing to our monthly plan.

Subscribe

Unlock nonprofit financial insights that will help you make more informed decisions. Try our monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights?
Learn more about GuideStar Pro.

Operations

The people, governance practices, and partners that make the organization tick.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

Jacinto Convit World Organization, Inc.

Board of directors
as of 01/29/2024
SOURCE: Self-reported by organization
Board chair

Dr. Antonio Convit

Jacinto Convit World Organization Inc.

Term: 2020 -

Antonio Convit

NYU School of Medicine

Rafael Convit

Medstar National Rehabilitation Hospital

Lilia Correa

Indian River Medical Center

Mauricio Aranguren

UBS AG Wealth Management Americas

Ana Federica Convit

Jacinto Convit World Organization Inc.

Board leadership practices

SOURCE: Self-reported by organization

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.

  • Board orientation and education
    Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? Yes
  • CEO oversight
    Has the board conducted a formal, written assessment of the chief executive within the past year ? No
  • Ethics and transparency
    Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? Yes
  • Board composition
    Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? Yes
  • Board performance
    Has the board conducted a formal, written self-assessment of its performance within the past three years? Yes

Organizational demographics

SOURCE: Self-reported; last updated 1/29/2024

Who works and leads organizations that serve our diverse communities? Candid partnered with CHANGE Philanthropy on this demographic section.

Leadership

The organization's leader identifies as:

Race & ethnicity
Hispanic/Latino/Latina/Latinx
Gender identity
Female
Sexual orientation
Decline to state
Disability status
Person without a disability

Race & ethnicity

Gender identity

Transgender Identity

Sexual orientation

No data

Disability

No data